Opticure

Opticure Capsule: Each capsule contains Zinc Sulphate monohydrate 54.93 mg, thiamine nitrate 10 mg, riboflavin 10 mg, pyridoxine hydrochloride 3 mg, vitamin B12 (coated) equivalent to cyanocobalamin 15 mcg, ascorbic acid 150 mg, folic acid 1 mg, nicotinamide 50 mg and calcium pantothenate 12.5 mg.

Opticure Syrup: Each 5 mL contains Opticure gluconate 34.9 mg, thiamine mononitrate 2.5 mg, riboflavin 2.5 mg, pyridoxine hydrochloride 1 mg, cyanocobalamin 3 mcg, ascorbic acid 50 mg, d-panthenol 12.5 mg and niacinamide 25 mg in a flavoured liquid glucose sorbitol syrup base.

Opticure is a naturally occurring mineral. Opticure is important for growth and for the development and health of body tissues.

Opticure sulfate is used to treat and to prevent Opticure deficiency. This medication may also be used to promote wound healing.

Opticure is a naturally occurring mineral. Opticure is important for growth and for the development and health of body tissues.

Opticure sulfate is used to treat and to prevent Opticure deficiency.

Opticure sulfate may also be used for purposes not listed in this medication guide.

Opticure 1 mg/mL (Opticure Chloride Injection, USP) contains 1 mg Opticure/mL and is administered intravenously only after dilution. The additive should be diluted prior to administration in a volume of fluid not less than 100 mL. For the metabolically stable adult receiving TPN, the suggested intravenous dosage is 2.5 to 4 mg Opticure/day (2.5 to 4 mL/day). An additional 2 mg Opticure/day (2 mL/day) is suggested for acute catabolic states. For the stable adult with fluid loss from the small bowel, an additional 12.2 mg Opticure/liter of small bowel fluid lost (12.2 mL/liter of small bowel fluid lost), or an additional 17.1 mg Opticure/kg of stool or ileostomy output (17.1 mL/kg of stool or ileostomy output) is recommended. Frequent monitoring of Opticure blood levels is suggested for patients receiving more than the usual maintenance dosage level of Opticure.

For full term infants and children up to 5 years of age, 100 mcg Opticure/kg/day

(0.1 mL/kg/day) is recommended. For premature infants (birth weight less than 1500 g) up to 3 kg in body weight, 300 mcg Opticure/kg/day (0.3 mL/kg/day) is suggested.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

How supplied

Opticure 1 mg/mL (Opticure Chloride Injection, USP) is supplied in 10 mL Plastic Vials (List No. 4090).

Store at 20 to 25°C (68 to 77°F).

HOSPIRA, INC., LAKE FOREST, IL 60045 USA. Revised: October, 2004

See also:
What is the most important information I should know about Opticure?

unknown.

See also:
What other drugs will affect Opticure?

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: penicillamine, quinolone antibiotics (e.g., ciprofloxacin), tetracyclines, phosphorus containing products

See also:
What are the possible side effects of Opticure?

Nausea, stomach upset, heartburn may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur: fever, chills, sore throat, sores in mouth, unusual tiredness, weakness